MEDINDIA

Search Medindia

Latest Press Releases

Health News Posted on Thursday, December 11, 2025

Premium Press Releases »

Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America

ADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new  Diversity in STEM Scholarships , a global initiative designed to support women and ...

Read More

Geneva College of Longevity Science and DrVibe.ai Launch the GCLS AI Academy for Longevity Sciences

New Website:  https://gcls.ai GENEVA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) , in partnership with DrVibe.ai , today announced the launch of the GCLS AI Academy for Longevity Sciences —the ...

Read More

CLINUVEL Expands Singapore RD&I Centre to Pioneer Next-generation Peptide Therapies

EXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery platforms existing RD&I teams will advance ...

Read More

Press Releases »

Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress

PR Newswire LONDON and NEW HAVEN, Conn., Dec. 11, 2025 LONDON and NEW HAVEN, Conn., Dec. 11, 2025 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) announced today that it presented clinical safety and efficacy data for BHV-1510 at the 2025 ...

Read More

Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial

PR Newswire INDIANAPOLIS, Dec. 11, 2025 In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of their body weight at 68 weeks Retatrutide reduced WOMAC pain scores by up to an ...

Read More

IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma

PR Newswire SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced it has completed its ...

Read More

ReGen Total Wellness Partners to Deliver Front-Line Mental Health Support to First Responders

PR Newswire TEMPE, Ariz., Dec. 11, 2025 Urgent: New Wellness Initiative Combats Record Burnout & PTSD in Police and Fire Departments. ReGen Total Wellness, an Arizona-based performance and recovery brand, has expanded its partnership with ...

Read More

ImpetusDX Introduces IDX Oral Health Microbial Testing Panel to Support More Informed Periodontal Care

PR Newswire PHOENIX, Dec. 11, 2025 PHOENIX, Dec. 11, 2025 /PRNewswire/ -- With periodontal disease affecting more than four in ten American adults and growing evidence connecting oral bacteria to conditions such as cardiovascular disease, ...

Read More

Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025

PR Newswire HONG KONG, Dec. 10, 2025 HONG KONG, Dec. 10, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ...

Read More

Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium

PR Newswire TOKYO, Dec. 10, 2025 - Data reflect new insights and precision oncology advancements in portfolio and pipeline - - Cohort results from Phase 2 ILUSTRO study evaluating a zolbetuximab triplet combination regimen in first-line ...

Read More

Senhwa Biosciences and BeOne Medicines Announces a Clinical Supply Agreement to Address the Challenge of Cold Tumors

PR Newswire TAIPEI and SAN DIEGO, Dec. 10, 2025 TAIPEI and SAN DIEGO, Dec. 10, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company developing first-in-class therapies for difficult-to-treat ...

Read More

ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification

PR Newswire PHILADELPHIA and IRVING, Texas, Dec. 10, 2025 New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence ...

Read More

Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight

PR Newswire LAS VEGAS, Dec. 10, 2025 The total pancreatic cancer market size is expected to increase in the 7MM during the forecast period, driven by ongoing clinical research and the development of better diagnostic tools, which may improve ...

Read More

Keep pets safe and happy this holiday season: Tips from the AVMA

PR Newswire SCHAUMBURG, Ill., Dec. 10, 2025 SCHAUMBURG, Ill., Dec. 10, 2025 /PRNewswire/ -- The holidays can be a magical time, but they can also present hidden pet hazards and difficult decisions for pet owners and gift-givers. The American ...

Read More

Privo Technologies Begins Dosing PRV131 in Arm 3 Of Clinical Study CLN-004, A First-In-Class Cisplatin Intratumoral Injectable Targeting Oral Cavity Cancer

PR Newswire BOSTON, Mass., Dec. 10, 2025 Key Highlights: BOSTON, Mass., Dec. 10, 2025 /PRNewswire/ -- Privo Technologies, Inc., today announced that the first patient has been dosed in its first-in-human clinical trial evaluating PRV131, ...

Read More

Bridgeway Behavioral Health Services Launches $2 Million Capital Campaign to Expand Outpatient Mental Health Services in Union County, NJ

PR Newswire UNION, N.J., Dec. 10, 2025 "A Legacy of Impact – A Future of Recovery" Will Revitalize Elizabeth Facility UNION, N.J., Dec. 10, 2025 /PRNewswire/ -- Bridgeway Behavioral Health Services has officially launched a $2 million ...

Read More

Empowering Better Outcomes: Mediaplanet Launches "Breast Health" Campaign

PR Newswire NEW YORK, Dec. 10, 2025 NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Breast cancer remains one of the most common cancers in the world — but advances in screening, diagnostic tools, and personalized treatment are transforming how ...

Read More

IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers

PR Newswire SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, announced the submission of an ...

Read More

Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment

PR Newswire HONG KONG, Dec. 10, 2025 -Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, ...

Read More

Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody

PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ...

Read More

FDA Approves the ProVee System - the First of a New Generation of Prostatic Urethral Stents for Treatment of BPH

PR Newswire DUBLIN, Dec. 9, 2025 DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it has ...

Read More

Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight

PR Newswire LAS VEGAS, Dec. 9, 2025 The amyotrophic lateral sclerosis market is expected to grow owing to the increasing prevalence of the disease, along with the promising emerging pipeline therapies, such as Masitinib (AB Sciences), PrimeC ...

Read More

Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants

PR Newswire SINGAPORE, Dec. 9, 2025 SINGAPORE, Dec. 9, 2025 /PRNewswire/ -- Immortal Dragons, the $40 million longevity-focused innovation fund, today announced its strategic investment in Etheros, a research-driven technology company ...

Read More

Cirius Therapeutics to Highlight Cardiometabolic Benefits of CIR-0602K at Global Cardiovascular Clinical Trialists (CVCT) Forum 2025

PR Newswire GRAND RAPIDS, Mich., Dec. 9, 2025 Data from Phase 2 Trials Underscore Cardioprotective Potential GRAND RAPIDS, Mich., Dec. 9, 2025 /PRNewswire/ -- Cirius Therapeutics, Inc., a developer of innovative therapies for people ...

Read More

Home Safety: Preventative Care Starts with a Safe Home

PR Newswire SACRAMENTO, Calif., Dec. 9, 2025 Evolve Releases Landmark White Paper on California's Home Modification Outcomes — Delivering a New Blueprint for Lower Healthcare Costs, Better Patient Outcomes, and Stronger Health Plan ...

Read More

NCCN Summit Seeks to Improve Care for Veterans and First Responders with Cancer from Line-of-Duty Exposure

PR Newswire WASHINGTON, Dec. 9, 2025 Speakers explore how we can better protect the heroes who protect us all. WASHINGTON, Dec. 9, 2025 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer ...

Read More

California Department of Public Health Issues Urgent Health Advisory: Silicosis Cases Surge Among Artificial Stone Countertop Workers

PR Newswire NOVATO, Calif., Dec. 9, 2025 NOVATO, Calif., Dec. 9, 2025 /PRNewswire/ -- Brayton Purcell LLP announces that the California Department of Public Health (CDPH) has issued a critical health advisory in response to a dramatic rise ...

Read More

Phanes Therapeutics to Present Phase 1/2 Study Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026

PR Newswire SAN DIEGO, Dec. 9, 2025 SAN DIEGO, Dec. 9, 2025 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that they will ...

Read More

Saol Therapeutics Has Been Granted a Type A Meeting with the FDA to Determine the Path Forward for SL1009 in Pyruvate Dehydrogenase Complex Deficiency (PDCD)

PR Newswire ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Dec. 9, 2025 FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an ...

Read More

American Lung Association Launches Campaign to Help New England Residents Stay Healthy This Winter

PR Newswire CHICAGO, Dec. 9, 2025 New campaign educates adults about vaccines that protect against flu, COVID-19 and RSV CHICAGO, Dec. 9, 2025 /PRNewswire/ -- Each winter, too many families across New England are impacted by respiratory ...

Read More

Exercise Might Help Improve Mobility During Aging

PR Newswire NEW YORK, Dec. 9, 2025 Study Findings May Provide Key Insight into Parkinson's Disease NEW YORK, Dec. 9, 2025 /PRNewswire/ -- The brain-chemical surge that comes with running may bolster coordination and speed in the old and ...

Read More

REVEALED: SKINCARE WOMEN NEGLECT DURING THE HOLIDAY SEASON, NEW RESEARCH FROM TENA

PR Newswire PHILADELPHIA, Dec. 9, 2025 PHILADELPHIA, Dec. 9, 2025 /PRNewswire/ -- As the festive season approaches and Americans prepare for weeks of holiday parties, colder weather and gift-shopping marathons, new research from TENA, the ...

Read More

Sweden Recommends: A Dose of Northern Lights Therapy

PR Newswire STOCKHOLM, Dec. 9, 2025 STOCKHOLM, Dec. 9, 2025 /PRNewswire/ -- As the world's first country to be prescribed for its health benefits, Sweden is now shining a light on one of its most awe-inducing wellness experiences. Aurora ...

Read More
More Press Releases
⬆️